Intervention Review

Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia

  1. William McGuire1,*,
  2. Peter W Fowlie2,
  3. David J Evans3

Editorial Group: Cochrane Neonatal Group

Published Online: 26 JAN 2004

Assessed as up-to-date: 19 MAR 2007

DOI: 10.1002/14651858.CD003955.pub2


How to Cite

McGuire W, Fowlie PW, Evans DJ. Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia. Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD003955. DOI: 10.1002/14651858.CD003955.pub2.

Author Information

  1. 1

    Australian National University Medical School, Department of Paediatrics and Child Health, Canberra, ACT 2606, Australia

  2. 2

    Ninewells Hospital and Medical School, Women & Child Health, Dundee, Scotland, UK

  3. 3

    Southmead Hospital, Neonatal Intensive Care Unit, Bristol, UK

*William McGuire, Department of Paediatrics and Child Health, Australian National University Medical School, Canberra Hospital Campus, Canberra, ACT 2606, Australia. william.mcguire@act.gov.au.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 26 JAN 2004

SEARCH